“…Moreover, some protein drugs, such as anti-PSMA mAbs, single-chain variable fragment (scFv) and soluble receptors have been used to target PCa [ 28 , 29 , 30 , 31 ]. For example, Indium-111 radio-labeled anti-PSMA mAb (mAb 7E11) has been approved by Food and Drug Administration (FDA) for the radiographic test of PCa [ 30 , 32 , 33 , 34 , 35 , 36 ] Some mAbs-conjugated immunotoxins or nanoparticles as PCa-targeted agents have been tested in clinical trials [ 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 ].…”